Genetic Mutation Linked to Severe Paralysis After Mild Infections in Children

Research has uncovered a genetic mutation in the RCC1 gene that causes severe nerve damage and paralysis in children following mild infections, offering new hope for diagnosis and treatment.
Scientists at the University of Manchester have identified a genetic condition that causes children to develop severe nerve damage and paralysis following mild infections. Their research revealed that mutations in the RCC1 gene are responsible for this unusual and devastating response. The study, titled "Acute-onset axonal neuropathy following infection in children with biallelic RCC1 variants," analyzed cases from multiple countries, including the UK, Turkey, Czechia, Germany, Iran, India, Saudi Arabia, Cyprus, and Slovakia. Among the cases studied, children experienced rapid nerve deterioration after infections such as flu or respiratory illnesses, which are typically mild. For example, Timothy Bingham, who first lost the ability to walk at age two after a flu, and an 8-month-old girl who required ventilator support after a chest infection, exemplify this condition. The research team conducted laboratory experiments on patient skin cells and genetically engineered fruit flies, demonstrating that chemical damage observed in nerve cells resembles conditions like motor neuron disease and Guillain-Barré syndrome. These findings not only elucidate the genetic cause behind these severe nerve reactions but also open avenues for early diagnosis and potential treatments. The discovery offers hope for at-risk children, suggesting that interventions could be implemented before nerve damage occurs. Experts emphasize that understanding this genetic link may also provide insights into more common nerve disorders, helping to develop targeted therapies. The study underscores the importance of genetic testing in children presenting with unexplained nerve weakness after mild infections and marks a significant step toward managing rare neurodegenerative conditions in pediatric populations.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Rivaroxaban Demonstrates Safety and Effectiveness for Long-Term Use in Children with Venous Thromboembolism
Recent long-term studies confirm that rivaroxaban is a safe and effective option for extended treatment of venous thromboembolism in children, offering a scientifically supported alternative to traditional therapies.
Enhanced Pre-Hospital Blood Pressure Monitoring to Prevent Brain Damage in Emergency Cases
Invasive arterial blood pressure monitoring in emergency care offers greater accuracy, potentially preventing brain damage in trauma patients. A recent KSS study highlights its importance for better treatment outcomes.
Artificial Intelligence Enhances Detection of High-Risk Colon Polyps
Artificial intelligence is revolutionizing colonoscopy by enabling even less experienced doctors to accurately identify dangerous colon polyps, improving early detection and prevention of colorectal cancer.
Innovative 'ALS on a Chip' Model Uncovers Changes in Motor Neuron Signaling
Cedars-Sinai has developed a novel 'organ-on-a-chip' model using patient-derived stem cells that reveals early alterations in motor neuron signaling linked to ALS, offering new avenues for understanding and treating the disease.